From the seven candidate markers, we identified PARP1 as a new promising diagnostic/prognostic biomarker for HCC and established a three-marker panel (PARP1, GS and NDRG1) greatly improving the diagnostic accuracy of HCC in liver nodules. The gene discussed is NDRG1; the disease is hepatocellular carcinoma.